Restricted accessResearch articleFirst published online 2012-11
Genetic Modification of Mesenchymal Stem Cells to Overexpress CXCR4 and CXCR7 Does Not Improve the Homing and Therapeutic Potentials of These Cells in Experimental Acute Kidney Injury
The therapeutic potential of bone marrow mesenchymal stem cells (MSCs) in kidney failure has been examined in some studies. However, recent findings indicate that after transplantation, these cells home to kidneys at very low levels. Interaction of stromal derived factor-1 (SDF-1) with its receptor, CXCR4, is of pivotal importance in migration and homing. Recently, CXCR7 has also been recognized as another SDF-1 receptor that interacts with CXCR4 and modulates its functions. In this study, CXCR4 and CXCR7 were separately and simultaneously overexpressed in BALB/c bone marrow MSCs by using a lentiviral vector system and the homing and renoprotective potentials of these cells were evaluated in a mouse model of cisplatin-induced acute kidney injury. Using flow cytometry, immunohistochemistry, and real-time PCR methods for detection of GFP-labeled MSCs, we found that although considerably entrapped in lungs, native MSCs home very rarely to kidneys and bone marrow and this rate cannot be significantly affected by CXCR4 and/or CXCR7 upregulation. Transplantation of neither native nor genetically engineered MSCs ameliorated kidney failure. We concluded that overexpression of CXCR4 and CXCR7 receptors in murine MSCs cannot improve the homing and therapeutic potentials of these cells and it can be due to severe chromosomal abnormalities that these cells bear during ex vivo expansion.
Get full access to this article
View all access options for this article.
References
1.
LiPK, WeeningJJ, DirksJ, LuiSL, SzetoCC, TangS, AtkinsRC, MitchWE, ChowKMet al.2005. A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong. June29, 2004. Kidney IntSuppl:S2–S7.
2.
Meguid El NahasA, BelloAK. 2005. Chronic kidney disease: the global challenge. Lancet, 365:331–340.
3.
PericoN, BenigniA, RemuzziG. 2008. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov, 7:936–953.
4.
HerreraMB, BussolatiB, BrunoS, FonsatoV, RomanazziGM, CamussiG. 2004. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med, 14:1035–1041.
5.
LinF, CordesK, LiL, HoodL, CouserWG, ShanklandSJ, IgarashiP. 2003. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol, 14:1188–1199.
6.
MorigiM, ImbertiB, ZojaC, CornaD, TomasoniS, AbbateM, RottoliD, AngiolettiS, BenigniAet al.2004. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol, 15:1794–1804.
7.
GuillotPV, CookHT, PuseyCD, FiskNM, HartenS, MossJ, ShoreI, Bou-GhariosG. 2008. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol, 214:627–636.
8.
LazzeriE, CrescioliC, RonconiE, MazzinghiB, SagrinatiC, NettiGS, AngelottiML, ParenteE, BalleriniLet al.2007. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol, 18:3128–3138.
KaleS, KarihalooA, ClarkPR, KashgarianM, KrauseDS, CantleyLG. 2003. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest, 112:42–49.
11.
DuffieldJS, ParkKM, HsiaoLL, KelleyVR, ScaddenDT, IchimuraT, BonventreJV. 2005. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest, 115:1743–1755.
12.
KrauseD, CantleyLG. 2005. Bone marrow plasticity revisited: protection or differentiation in the kidney tubule?J Clin Invest, 115:1705–1708.
13.
TogelF, HuZ, WeissK, IsaacJ, LangeC, WestenfelderC. 2005. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol, 289:F31–F42.
14.
BiB, SchmittR, IsrailovaM, NishioH, CantleyLG. 2007. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol, 18:2486–2496.
15.
DuffieldJS, BonventreJV. 2005. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int, 68:1956–1961.
KolletO, ShivtielS, ChenYQ, SuriawinataJ, ThungSN, DabevaMD, KahnJ, SpiegelA, DarAet al.2003. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest, 112:160–169.
18.
PonomaryovT, PeledA, PetitI, TaichmanRS, HablerL, SandbankJ, Arenzana-SeisdedosF, MagerusA, CaruzAet al.2000. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest, 106:1331–1339.
19.
WojakowskiW, TenderaM, MichalowskaA, MajkaM, KuciaM, MaslankiewiczK, WyderkaR, OchalaA, RatajczakMZ. 2004. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation, 110:3213–3220.
20.
AhmadbeigiN, SeyedjafariE, GheisariY, AtashiA, OmidkhodaA, SoleimaniM. 2010. Surface expression of CXCR4 in unrestricted somatic stem cells and its regulation by growth factors. Cell Biol Int, 34:687–692.
21.
HonczarenkoM, LeY, SwierkowskiM, GhiranI, GlodekAM, SilbersteinLE. 2006. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells, 24:1030–1041.
KahnJ, BykT, Jansson-SjostrandL, PetitI, ShivtielS, NaglerA, HardanI, DeutschV, GazitZet al.2004. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood, 103:2942–2949.
24.
AbbottJD, HuangY, LiuD, HickeyR, KrauseDS, GiordanoFJ. 2004. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 110:3300–3305.
25.
AiutiA, WebbIJ, BleulC, SpringerT, Gutierrez-RamosJC. 1997. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med, 185:111–120.
26.
AskariAT, UnzekS, PopovicZB, GoldmanCK, ForudiF, KiedrowskiM, RovnerA, EllisSG, ThomasJDet al.2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet, 362:697–703.
27.
KortesidisA, ZannettinoA, IsenmannS, ShiS, LapidotT, GronthosS. 2005. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood, 105:3793–3801.
28.
LevoyeA, BalabanianK, BaleuxF, BachelerieF, LaganeB. 2009. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood, 113:6085–6093.
29.
SierroF, BibenC, Martinez-MunozL, MelladoM, RansohoffRM, LiM, WoehlB, LeungH, GroomJet al.2007. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A, 104:14759–14764.
30.
MazzinghiB, RonconiE, LazzeriE, SagrinatiC, BalleriniL, AngelottiML, ParenteE, MancinaR, NettiGSet al.2008. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med, 205:479–490.
31.
DobsonKR, ReadingL, HabereyM, MarineX, ScuttA. 1999. Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int, 65:411–413.
32.
PeisterA, MelladJA, LarsonBL, HallBM, GibsonLF, ProckopDJ. 2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood, 103:1662–1668.
33.
NaldiniL, BlomerU, GallayP, OryD, MulliganR, GageFH, VermaIM, TronoD. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272:263–267.
34.
ChatterjeePK, BrownPA, CuzzocreaS, ZacharowskiK, StewartKN, Mota-FilipeH, McDonaldMC, ThiemermannC. 2001. Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int, 59:2073–2083.
35.
FaubelS, LewisEC, ReznikovL, LjubanovicD, HokeTS, SomersetH, OhDJ, LuL, KleinCL, DinarelloCA, EdelsteinCL. 2007. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther, 322:8–15.
36.
CastellaniS, AdamsPM. 1981. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol, 73:143–154.
37.
AlexandreCS, VolpiniRA, ShimizuMH, SanchesTR, SemedoP, di JuraVL, CamaraNO, SeguroAC, AndradeL. 2009. Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells, 27:682–692.
38.
KyriakouC, RabinN, PizzeyA, NathwaniA, YongK. 2008. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica, 93:1457–1465.
39.
BaddooM, HillK, WilkinsonR, GauppD, HughesC, KopenGC, PhinneyDG. 2003. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem, 89:1235–1249.
40.
Meirelles LdaS, NardiNB. 2003. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol, 123:702–711.
41.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD, HorwitzE. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
42.
TogelF, CohenA, ZhangP, YangY, HuZ, WestenfelderC. 2009. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev, 18:475–485.
43.
GheisariY, SoleimaniM, AzadmaneshK, ZeinaliS. 2008. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy, 10:815–823.
44.
WagstaffMJ, LilleyCE, SmithJ, RobinsonMJ, CoffinRS, LatchmanDS. 1998. Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo. Gene Ther, 5:1566–1570.
45.
LeeRH, PulinAA, SeoMJ, KotaDJ, YlostaloJ, LarsonBL, Semprun-PrietoL, DelafontaineP, ProckopDJ. 2009. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell, 5:54–63.
StrooI, StokmanG, TeskeGJ, FlorquinS, LeemansJC. 2009. Haematopoietic stem cell migration to the ischemic damaged kidney is not altered by manipulating the SDF-1/CXCR4-axis. Nephrol Dial Transplant, 24:2082–2088.
48.
TogelF, IsaacJ, HuZ, WeissK, WestenfelderC. 2005. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int, 67:1772–1784.
49.
BonigH, PriestleyGV, PapayannopoulouT. 2006. Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. Blood, 107:79–86.
50.
LeeRH, SongJM, ParkMY, KangSK, KimYK, JungJS. 2001. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol, 62:1013–1023.
51.
LieberthalW, TriacaV, LevineJ. 1996. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol, 270:F700–F708.
52.
BehrL, HekmatiM, LucchiniA, HoucinetK, FaussatAM, BorensteinN, NoelLH, Lelievre-PegorierM, LabordeK. 2009. Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury. Cell Prolif, 42:284–297.
AguilarS, NyeE, ChanJ, LoebingerM, Spencer-DeneB, FiskN, StampG, BonnetD, JanesSM. 2007. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells, 25:1586–1594.
57.
AhmadbeigiN, SoleimaniM, GheisariY, VaseiM, AmanpourS, BagherizadehI, ShariatiSA, AzadmaneshK, AminiSet al.2011. Dormant phase and multinuclear cells: two key phenomena in early culture of murine bone marrow mesenchymal stem cells. Stem Cells Dev, 20:1337–1347.
58.
MiuraM, MiuraY, Padilla-NashHM, MolinoloAA, FuB, PatelV, SeoBM, SonoyamaW, ZhengJJet al.2006. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells, 24:1095–1103.
59.
ZhouYF, Bosch-MarceM, OkuyamaH, KrishnamacharyB, KimuraH, ZhangL, HusoDL, SemenzaGL. 2006. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res, 66:10849–10854.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
